Forendo Pharma, a clinical-stage drug development company focusing on novel treatments in women’s health, has signed a license-and-collaboration agreement with Novartis. The joint research collaboration is aimed at identification of…Read More
Merck, through a subsidiary, is commencing a cash tender offer to purchase all outstanding shares of common stock of ArQule, Inc. On December 9, 2019, Merck announced its intent to…Read More
Mankind Pharmaceuticals has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country. Under the sub-licensing agreement, Mankind will market the drug under its…Read More
The US Food and Drug Administration (FDA) has accepted the Novartis’ supplemental Biologics License Application (sBLA) for Xolair (Omalizumab) for the treatment of nasal polyps in adult patients, 18 years…Read More
BioInvent International AB, a biotech company focused on the discovery and development of novel and first-in-class immuno-modulatory antibodies for cancer immunotherapy, and Transgene, a biotech company that designs and develops…Read More
The US Food and Drug Administration (FDA) approved Atezolizumab (Tecentriq, Genentech/Roche) in combination with chemotherapy nab-paclitaxel (Abraxane, Celgene) and carboplatin for the first-line treatment of metastatic non-squamous non-small-cell lung cancer…Read More
The US Food and Drug Administration has approved three applications for first generics of Gilenya (fingolimod) capsules for the treatment of relapsing forms of multiple sclerosis (MS) in adult patients….Read More
The US Food and Drug Administration has declined Enzyvant’s regenerative tissue therapy for a rare immunodeficiency disorder and raised concerns about its manufacturing. The company was hoping to win its…Read More
Glenmark Pharmaceuticals Inc. has been granted abbreviated new drug application (ANDA) approval by the US Food & Drug Administration (USFDA) for its Abiraterone Acetate tablets USP, 250 mg, a generic…Read More
Cipla has acquired a patented anti-infective drug Elores from Venus Remedies Ltd. The product is used for the treatment of life-threatening infections caused by certain bacteria. The company feels that…Read More
Sun Pharma’s subsidiary has launched Drizalma Sprinkle in the US. It is the first and only USFDA-approved sprinkle formulation of Drizalma Sprinkle, which is delayed-release duloxetine capsules used in treatment…Read More
GlaxoSmithKline plc has announced a five-year collaboration with Lyell Immunopharma to develop new technologies to improve cell therapies for cancer patients. The collaboration will apply Lyell’s technologies to further strengthen…Read More
Shield Healthcare has acquired Brio Bliss Life Science and Nutri Synapzz Therapeutics. Following the acquisitions, Shield Healthcare aims to increase its presence in gynecology and pediatrics. Brio Bliss Life Science…Read More
Granules India Ltd. has decided to divest its entire equity shareholding in its Chinese joint venture, Granules Biocause Pharmaceuticals. The latter is an equal joint venture between Granules India and…Read More
